Cardinal Health ranked 9th Greenest Company in the nation by Newsweek

Posted by BioOhio on Jun. 11, 2014

Cardinal Health 400Dublin, Ohio based Cardinal Health, long time BioOhio member, has been ranked as America’s 9th greenest company in Newsweek’s 2014 Green Rankings, released in partnership with Corporate Knights Capital, leading sustainability minds from nongovernmental organizations and the academic and accounting communities.

The study’s parameters included productivity in energy, carbon, water and waste, as well as the company’s reputation and sustainability outlook. Cardinal Health placed third in the Health Care sector, and ranked first among Ohio companies in the study. View the full report on Newsweek’s site, here.

BioOhio Summer Socials, bioscience networking at its best, this Wednesday in Cleveland at Market Garden Brewery!

Posted by BioOhio on Jun. 09, 2014

Event-SS-Northeast2014BioOhio’s fun summer socials bring Ohio’s bioscience players together for networking, talking shop, and getting to know one another in a casual atmosphere. The event will be held from 4 to 6pm. Click here for details, location and registration information.

Complimentary hors d’oeuvres for all guests; 1 drink ticket for BioOhio members, and that includes employees of member organizations. Happy hour cash bar for non-members. Our social in Southwest Ohio on June 4th was a great success and we’re looking forward to Central Ohio on June 18th.

Prior to each BioOhio Summer Social, we will host an informational session titled “Services to Accelerate Growth and Increase $avings

Taking place 2:45-3:45, this session will cover BioOhio services which address savings, efficiency, productivity and retention in the employee life cycle (talent, technology, training, together), as well as cover other useful money-saving member benefits. Content will be delivered by colleagues from Taylor Strategy Partners, Sequent, and BioOhio. Please notify Jen Goldsberry (jgoldsberry@bioohio.com) if you plan to attend the info session.

Congressman David Joyce visits Neuros Medical for facility tour and discussion

Posted by BioOhio on May. 29, 2014
(L-R) Congressman David Joyce (second from right) shown with the Management Team at Neuros Medical, Chief Scientific Officer Dr. Zi-Ping Fang, Founder, President and CEO Jon J. Snyder, and Chief Financial Officer Mark Teague, during a recent visit to Neuros.

(L-R) Congressman David Joyce (second from right) shown with the Management Team at Neuros Medical, Chief Scientific Officer Dr. Zi-Ping Fang, Founder, President and CEO Jon J. Snyder, and Chief Financial Officer Mark Teague, during a recent visit to Neuros.

As the Ohio affiliate of AdvaMed, BIO, MDMA and PhRMA, BioOhio participates in advocacy for issues that matter to our members. Many of our members are actively involved with their local, state and federal representatives.

Congressman David Joyce of Ohio’s 14th District visited Neuros Medical in Willoughby Hills, Ohio for a site tour and roundtable discussion.

Neuros is in the initial stages of their randomized, controlled pivotal clinical trial to evaluate the Company’s patented Altius® High Frequency Nerve Block System for the management of intractable limb pain of amputees.

The study consists of 130 patients at 15 medical centers in the U.S. When completed, the results will support a PreMarket Approval Application to FDA in order to market the device. The pivotal study builds upon their long-term pilot study which reported significant pain reduction. In addition, more than half of the subjects discontinued their pain medication use during the study.

“We were pleased and honored to welcome Representative Joyce to Neuros,” said Jon J. Snyder, President and CEO of Neuros Medical. “We appreciate his interest in our Altius System and the potential it holds for patients suffering from chronic pain.”

Representative Joyce was first elected in November 2012 and represents Ashtabula, Geauga, Lake and parts of Cuyahoga, Summit, Trumbull, and Portage counties.

Neuros-Medical-LogoNeuros Medical is focused on developing proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of conditions including amputation pain, post-surgical pain, migraine, and trigeminal neuralgia.

BioOhio BioBulletin, May 2014

Posted by BioOhio on May. 20, 2014
     

BioBulletin

         John Lewis

Welcome to the 5th edition of the BioOhio BioBulletin.

Trivia: Did you know that children grow fastest in the springtime?

This BioBulletin edition is again focused on events. Mark your calendars, share with colleagues, and register now! Event sponsorships are available at various levels, so commit early for more visibility.

My advice continues: Engage, Bring It!

Events

 June 4 - BioOhio Summer Socials – Southwest Ohio at 50 West Brewing Company
June 11 – BioOhio Summer Socials – Northeast Ohio at Market Garden Brewery
June 18 – BioOhio Summer Socials – Central Ohio at Miller’s Columbus Ale House

 

Summer Socials

Join us for bioscience networking at its finest!

BioOhio’s fun summer socials bring Ohio’s bioscience players together for networking, talking shop, and getting to know one another in a casual atmosphere. Complimentary hors d’oeuvres for all guests, and members, the first drink is on us! Thanks to Taylor Strategy Partners for sponsor support! Additional sponsorship opportunities are available. Click on the links above to register. Those who attend all 3 will receive a special prize!

Prior to each BioOhio Summer Social, we will host an informational session titled “Services to Accelerate Growth and Increase $avings.” Taking place 2:45-3:45, this session will cover BioOhio services which address savings, efficiency, productivity and retention in the employee life cycle (talent, technology, training, together), as well as cover other useful money-saving member benefits. Content will be delivered by colleagues from Taylor Strategy Partners, Sequent, and BioOhio. Notify Jen Goldsberry (jgoldsberry@bioohio.com) if you plan to attend the info session.

August 5 – Ohio Bioscience Expo & Showcase

BertramCalling all Exhibitors! This event will be MD&M + BIO + AdvaMed + Pittcon + RS&A + MEDICA + HIMMS + ACRP + ASCO+++, all rolled into one. If you’re an established or start-up bioscience company, supplier, service provider, or innovator, you need to exhibit at this event. Exhibitors and attendees alike will connect with new customers, find new collaborators and partners, meet colleagues in the industry, and discover companies making cutting edge products and delivering quality services. Our previous expo had 86 exhibitors and we anticipate more this year. We have a super location in Aurora, located between Cleveland and Akron, at the stunning Bertram Inn & Conference Center. Book your exhibitor space now, and sponsorship opportunities are available.

(more…)

Nationwide Children’s Hospital partners to form the Children’s Oncology Drug Alliance

Posted by BioOhio on May. 08, 2014

Nationwide Children's HospitalBioOhio is all about connections and partnerships, and we are always excited to hear about new alliances, especially when they not only cross state borders, but entire hemispheres.

Ohio Australia

Long time BioOhio member, Nationwide Children’s Hospital of Columbus, Ohio recently announced they have formed a research and development partnership with researchers and children’s cancer advocates in Australia to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants. Currently there is no medicine approved to treat neuroblastoma, a cancer that affects up to 100 children in Australia and around 650 in the United States each year.

The Children’s Oncology Drug Alliance (CODA) unites the research and resources of the University of New South Wales (UNSW) in Australia and its commercialization arm, NewSouth Innovations; The Kids’ Cancer Project, an Australia-based childhood cancer research charity; and Novogen, an Australian oncology drug development company.

(more…)

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Battelle acquires part of WA based Advanced Medical Isotope Corporation | PR Newswire, July 7, 2014

Sinclair Community College President Steven Johnson discusses education, change and the future | Dayton Business Journal, July 7, 2014

Team NEO report: Health care critical to economy, medical-related research also strong | Akron Beacon Journal, July 6, 2014

Ohio State Univeristy College of Medicine marks 100 years | Columbus Dispatch, July 6, 2014

Kim Koss, scientist and patient, uses her own cancer to further research | Cincinnati.com, July 5, 2014

Cardinal Health: 7 lessons the medical device supply chain can learn from the auto industry | PR Newswire, July 1, 2014

Ricerca Biosciences announces completion of an EPA Office Of Compliance FIFRA Inspection | PR Newswire, July 1, 2014

Nationwide Children’s Hospital opens new Close to Home Center in Clintonville | ThisWeek Community News, July 1, 2014

Thermedx receives FDA 510(k) for arthroscopy and hysteroscopy fluid warming | PR Newswire, June 30, 2014

Salmonella detector invented by Ohio State University spinout ProteoSense lands $100K Third Frontier grant | Columbus Business First, June 30, 2014

Rutgers’ Big Ten membership strengthens collaboration with Ohio State University’s biotechnology program | Rutgers University, June 30, 2014

Surgical Theater’s Surgical Navigation Advanced Platform (SNAP) receives FDA clearance | PR Newswire, June 30, 2014

Advanced Biological Marketing announces new patent to improve plant growth | PR Web, June 30, 2014

John Castellani, PhRMA President and CEO: Restricting access to medicines at the expense of patients warrants a candid conversation | PhRMA, June 30, 2014

Students from Fairland Middle School honored at State Science Day | Herald Dispatch, June 29, 2014

Interview with Gary Fingerhut, Cleveland Clinic Executive Director, technology allows us to put patients first | MedCity News, June 28, 2014

Profile of Chad Bouton, part of the creative team behind Neurobridge, developed by Battelle and Ohio State University’s Wexner Medical Center | Ames Tribune, June 28, 2014

Nanologix granted European patent for BioNanoPore, joining the patent portfolio for BNP in Japan and Russia | NanoLogix, June 27, 2014

Norman Noble expands process development centers in Highland Heights, OH (pdf) | Norman Noble, June 27, 2014

FDA grants orphan drug designation to Airway Therapeutics, helping premature babies avoid bronchopulmonary dysplasia (BPD) | Cincinnati.com, June 26, 2014